Adenosine: Difference between revisions
Ostermayer (talk | contribs) (Text replacement - "Hypotension " to "Hypotension") |
(Text replacement - "OR" to "'''OR'''") |
||
| Line 12: | Line 12: | ||
**Higher dose (1st 12mg, 2nd/3rd 18mg) in patient taking methylxanthines (ie caffeine, theophylline) | **Higher dose (1st 12mg, 2nd/3rd 18mg) in patient taking methylxanthines (ie caffeine, theophylline) | ||
***Blocks adenosine binding at receptor sites (competitive antagonist) | ***Blocks adenosine binding at receptor sites (competitive antagonist) | ||
**Lower dose (1st 3mg, 2nd/3rd 6mg) in patient taking carbamazepine (Tegretol), diazepam (Valium) or dipyridamole (Persantine) OR with a heart transplant. | **Lower dose (1st 3mg, 2nd/3rd 6mg) in patient taking carbamazepine (Tegretol), diazepam (Valium) or dipyridamole (Persantine) '''OR''' with a heart transplant. | ||
===Indications=== | ===Indications=== | ||
Revision as of 01:45, 31 May 2017
See critical care quick reference for drug doses by weight.
General
- Type: Antiarrhythmics
- Dosage Forms:
- Common Trade Names:
Adult Dosing
- 6mg rapid IV bolus over 1-2s
- If ineffective can try 12mg 2min later
- If still ineffective can try another 12mg
- If ineffective can try 12mg 2min later
- Caveat
- Higher dose (1st 12mg, 2nd/3rd 18mg) in patient taking methylxanthines (ie caffeine, theophylline)
- Blocks adenosine binding at receptor sites (competitive antagonist)
- Lower dose (1st 3mg, 2nd/3rd 6mg) in patient taking carbamazepine (Tegretol), diazepam (Valium) or dipyridamole (Persantine) OR with a heart transplant.
- Higher dose (1st 12mg, 2nd/3rd 18mg) in patient taking methylxanthines (ie caffeine, theophylline)
Indications
- Conversion of reentrant PSVT to NSR
Pediatric Dosing
See critical care quick reference for drug doses by weight.
Special Populations
- Pregnancy Rating: Category C
- Lactation:
- Renal Dosing
- Adult
- Pediatric
- Hepatic Dosing
- Adult
- Pediatric
Contraindications
- Allergy to class/drug
- 2nd, 3rd AV block
- Sick sinus syndrome
- Reentrant SVTs not involving AV node are not terminated
- No effect on anterograde WPW
Adverse Reactions
- Bronchoconstriction (responds to bronchodilators)
- Bradyarrhythmia
- Hypotension(if given too slowly)
Pharmacology
- Kinetics: Onset of action = 20-30s Duration of action = 60-90s
- Half-life:
- Metabolism:
- Excretion:
Mechanism of Action
- Negative inotropic, dromotropic, chronotropic effects
- Transient AV nodal block
